Condition

HER2 Positive Solid Tumors (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Silverback Therapeutics (1)

Collaborator

Intervention

cemiplimab (1)

pembrolizumab (1)

sbt6050 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

her2 positive solid tumors

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HER2 Positive Solid Tumors Trial in Australia, Korea, Republic of, United States (SBT6050, pembrolizumab, Cemiplimab)

Active, not recruiting

HER2 Positive Solid Tumors

SBT6050
+2 more

Boston, Massachusetts
+11 more

Jun 27, 2022